{"doi":"10.1016/j.jcf.2025.02.002","title":"Real-world outcomes of generic elexacaftor/tezacaftor/ivacaftor (gETI) in South Africans (SA) with CF using standard versus clarithromycin-boosted gETI, modulator-sparing strategies to reduce cost","abstract":null,"journal":"Journal of Cystic Fibrosis","year":2025,"id":605317,"datarank":0.32958368660043297,"base_score":2.1972245773362196,"endowment":2.1972245773362196,"self_citation_contribution":0.32958368660043297,"citation_network_contribution":0.0,"self_endowment_contribution":0.32958368660043297,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":8,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1553444,"name":"Janine Verstraete","orcid":"0000-0002-1148-4747","position":1,"is_corresponding":false},{"id":1553445,"name":"Cathy Baird","orcid":null,"position":2,"is_corresponding":false},{"id":1553446,"name":"Tony Biebuyck","orcid":"0009-0009-8588-5250","position":3,"is_corresponding":false},{"id":110204,"name":"Greg Calligaro","orcid":"0000-0001-7324-0775","position":4,"is_corresponding":false},{"id":1553447,"name":"Marina Coetzee","orcid":null,"position":5,"is_corresponding":false},{"id":1553448,"name":"Carla Els","orcid":null,"position":6,"is_corresponding":false},{"id":1210445,"name":"Marlize Frauendorf","orcid":null,"position":7,"is_corresponding":false},{"id":1553449,"name":"Paul Gebers","orcid":null,"position":8,"is_corresponding":false},{"id":1553450,"name":"Brenda Morrow","orcid":null,"position":9,"is_corresponding":false},{"id":1553451,"name":"Dave Richards","orcid":null,"position":10,"is_corresponding":false},{"id":1553452,"name":"Hanri Truter","orcid":null,"position":11,"is_corresponding":false},{"id":1001161,"name":"Andrew Hill","orcid":"0000-0001-5468-6616","position":12,"is_corresponding":false},{"id":1553443,"name":"Marco Zampoli","orcid":"0000-0002-6899-6137","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Real-world outcomes of generic elexacaftor/tezacaftor/ivacaftor (gETI) in South Africans (SA) with CF using standard versus clarithromycin-boosted gETI, modulator-sparing strategies to reduce cost","abstract":null,"is_dataset_classified":null,"base_score":0.0,"endowment":0.0,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"23304386","pmcid":null,"openalex_id":null,"authors":[],"funders":[],"total_grants":0,"fwci":null,"citation_percentile":null,"influential_citations":0,"citation_trend":[],"oa_status":"hybrid","license":"cc-by","oa_locations":[{"url":"https://www.cysticfibrosisjournal.com/article/S1569-1993(25)00051-7/pdf","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S1569199325000517?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S1569199325000517?httpAccept=text/plain","host_type":"publisher"}],"fields_of_study":[],"mesh_terms":[],"keywords":[],"sdg_mappings":[],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-07-30T02:10:17.777328Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}